DailyIQ
Last updated 4 minutes ago

RJF·Raymond James Financial, Inc.

$.
-. (-.%)
After Hours
High
$169.74
Open
$168.63
Market Cap
32.91B
52W High
$177.66
Low
$166.66
P. Close
$168.11
P/E
15.33
52W Low
$138.82
Fwd P/E
11.83
DailyIQ Est.
$184.02
Technical Score (1D)
86
BUY
News Sentiment
69
BULLISH
Raymond James is being described as roughly 32 % undervalued based on its strong Q1 growth, a view that has emerged from two 43.9‑hour‑old analyst reports. The reports highlight a 13.4 % year‑on‑year revenue increase to $3.86 billion and rising earnings per share, suggesting the firm’s fee‑income base remains robust. Because the intrinsic value estimates indicate upside while earnings multiples appear near fair, the market may see room for a modest rally over the next 1–10 trading days. Traders should monitor the next earnings guidance for any shift in growth expectations, as well as macro‑economic data that could influence the financial services sector. JPMorgan’s price target lift to $175 from $168, and Morgan Stanley’s upgrade to an Equal‑Weight rating with a $174 target, both reinforce the optimistic outlook for RJF’s earnings trajectory. These upgrades suggest that analysts expect continued fee‑income growth, but the firm’s exposure to U.S. market dynamics and commission compression remains a potential risk. Watch for any regulatory updates or changes in capital requirements that could affect the broker‑dealer’s profitability, as well as the firm’s guidance on fee‑income growth. A whistleblower lawsuit alleging mismanagement of Medicare Advantage contracts was deemed overblown by analysts, which has helped maintain confidence in RJF’s compliance framework. Traders should keep an eye on any further regulatory scrutiny or updates to Medicare Advantage rules that could impact fee income.
Earnings Summary
Raymond James Financial, Inc. is a diversified financial services firm headquartered in Florida that delivers wealth management, investment banking, brokerage, and asset‑management solutions across North America and Europe, positioning it within the broader financial services sector and specifically the asset‑management industry. In the most recent reporting cycle, the company’s Q1 2026 revenue rose to $3.735 billion, up 9.7% from $3.403 billion in Q1 2025, while Q2 2026 revenue climbed 13.5% to $3.859 billion versus $3.398 billion in Q2 2025, reflecting a steady acceleration in fee‑income growth; EPS in Q1 2026 was $2.86, slightly below the $2.9034 consensus, whereas Q2 2026 EPS of $2.83 beat the $2.8031 estimate, and the firm had also beaten estimates in Q3 2025 and Q4 2024, achieving EPS of $3.11 and $2.93 versus forecasts of $2.82799 and $2.69298, respectively, indicating a 3‑of‑4 quarter earnings‑beat streak. Historically, Raymond James has maintained a consistent YoY revenue expansion, with double‑digit growth in each of the last two quarters and EPS growth exceeding 18% in Q1 2026 and nearly 30% in Q2 2026, underscoring a robust fee‑income base even as the firm occasionally misses guidance, as seen in Q1 2026; the pattern of revenue growth paired with occasional EPS misses suggests margin pressure may be a recurring theme. Recent analyst activity has highlighted valuation uncertainty, with JPMorgan and Morgan Stanley raising price targets to $175–$174 amid a 13.4% YoY revenue rise and earnings‑per‑share beat, while a whistleblower lawsuit dismissal reinforced confidence in regulatory compliance, and the SpaceX IPO mandate has been cited as a potential revenue driver; these developments suggest that market sentiment may pivot on the firm’s ability to sustain underwriting fees and navigate macro‑economic headwinds. Forward‑looking watch points for investors include monitoring the upcoming earnings guidance for any revisions to revenue or margin expectations, assessing the impact of the SpaceX mandate and Medicare compliance outcomes on fee income, and staying alert to regulatory changes that could affect capital or fee‑structure rules, as these factors will be key to understanding the firm’s near‑term earnings trajectory.}}

EPS

EstBeatMiss
$2.04$2.34$2.65$2.95$3.25Q1'25Q2'25Q3'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$2.91 - -
Q2'26$2.80$2.83+1.0%
Q1'26$2.90$2.86-1.5%
Q3'25$2.83$3.11+10.0%
Q2'25$2.36$2.18-7.5%
Q1'25$2.44$2.42-0.7%

Revenue

EstBeatMiss
$3.3B$3.5B$3.7B$3.9B$4.1BQ1'25Q2'25Q3'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$4.0B - -
Q2'26$3.9B$3.9B-1.2%
Q1'26$4.0B$3.7B-5.7%
Q3'25 - $3.7B -
Q2'25 - $3.4B -
Q1'25 - $3.4B -

Market Data

RJF Stock Snapshot

RJF is currently trading at $168.12, giving Raymond James Financial, Inc. a market cap of 32.91B and a P/E ratio of 15.3. Today's range spans $166.66–$169.74, with shares opening at $168.63 and moving up $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 86/100 (BUY) with a news sentiment reading of 69/100.

Over the past year RJF has traded between $138.82 and $177.66 - the current price is +21.1% off the 52-week low and -5.4% from the high. 20 analysts cover the stock with a Hold consensus and a mean 12-month target of $182.67 (range $160.00–$205.00), implying upside of +8.7%.

RJF is showing the kind of bullish setup that active managers add to on dips - 86/100 (BUY), bullish sentiment at 69/100, 32.91B market cap in Financial Services, price $168.12 (in the upper portion of its 52-week range). The current P/E ratio stands at 15.3. At this cap tier, the combination of technical confirmation and positive sentiment is what separates speculative bullish positions from high-conviction ones. Annual range: $138.82–$177.66. The setup is in the latter category.

What makes RJF's BUY setup (86/100) particularly actionable at 32.91B in Financial Services capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $168.12 (in the upper portion of its 52-week range in $138.82–$177.66), with sentiment running bullish at 69/100, the setup rewards conviction-sized positioning more than it does speculative small bets.